Drugs Made In America Acquisition Corp DMAA Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$10.89 up $0.01, 0.09% at close Nov 5
Last close · Previous close $10.88
- Market cap
- At the Nov 5 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$10.89up $0.01, 0.09%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$10.88Nov 4
- Volume845.00Nov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume13.74KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $10.31 to $10.89; now $10.89
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
DMAA beat the S&P 500 in 2 of 4 periods.
| Period | DMAA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | DMAA: unchanged S&P 500: down 5.4% | DMAA beat the S&P 500 by 5.4 percentage points Beat |
| 3M | DMAA: up 1.7% S&P 500: down 4.5% | DMAA beat the S&P 500 by 6.2 percentage points Beat |
| YTD | DMAA: up 5.0% S&P 500: up 8.3% | DMAA trailed the S&P 500 by 3.3 percentage points Trailed |
| 1Y | DMAA: up 5.5% S&P 500: up 9.3% | DMAA trailed the S&P 500 by 3.8 percentage points Trailed |
$10,000 invested in DMAA a year ago (Nov 5, 2025) would be worth about $10,552 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $10,934.
DMAA beat the S&P 500 in 2 of 4 periods.
| Period | DMAA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | DMAA: unchanged S&P 500: down 5.4% | DMAA beat the S&P 500 by 5.4 percentage points Beat |
| 3M | DMAA: up 1.7% S&P 500: down 4.8% | DMAA beat the S&P 500 by 6.5 percentage points Beat |
| YTD | DMAA: up 5.0% S&P 500: up 7.5% | DMAA trailed the S&P 500 by 2.5 percentage points Trailed |
| 1Y | DMAA: up 5.5% S&P 500: up 8.2% | DMAA trailed the S&P 500 by 2.7 percentage points Trailed |
$10,000 invested in DMAA a year ago (Nov 5, 2025) would be worth about $10,552 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $10,818.
All-time high
$10.89
Closing high on .
Split-adjusted daily closes since Feb 25, 2025.
Stock splits
DMAA hasn’t split since its price history begins in 2025.
Valuation
Financials
About Drugs Made In America Acquisition Corp
Drugs Made In America Acquisition Corp
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
DMAA news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
DMAA stock FAQ
What is DMAA stock’s price today?
Drugs Made In America Acquisition (DMAA) traded at $10.89 at the close on , up $0.01 (0.09%) from the previous close of $10.88. Over the past 52 weeks it has traded between $10.31 and $10.89.
Does DMAA pay a dividend?
Drugs Made In America Acquisition hasn’t paid a dividend in the last twelve months.
What is DMAA’s 52-week high and low?
Over the past 52 weeks DMAA has traded as low as $10.31 and as high as $10.89. At $10.89 at the close on , it is 0.0% below that high and 5.6% above the low.
What is DMAA’s all-time high?
DMAA’s highest closing price was $10.89 on , adjusted for stock splits.
Has DMAA stock ever split?
No. DMAA hasn’t split since its price history begins in 2025.
How has DMAA stock performed?
Including dividends and measured to the close on , DMAA has returned +5.0% so far this year and +5.5% over the past year. Over the same periods the S&P 500, measured by SPY, returned +8.3% and +9.3%. Past performance doesn’t predict future returns.
What exchange does DMAA trade on?
Drugs Made In America Acquisition trades on the Nasdaq under the ticker symbol DMAA. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.